medRxiv preprint doi: https://doi.org/10.1101/2021.03.23.21254185; this version posted March 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Early super-spreader events are a likely determinant of novel SARS-CoV-2 variant
predominance
Ashish Goyal1, Daniel Reeves1, Joshua T. Schiffer1,2,3
1 Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center
2 Department of Medicine, University of Washington, Seattle
3 Clinical Research Division, Fred Hutchinson Cancer Research Center
Corresponding author: Joshua T. Schiffer, jschiffe@fredhutch.org

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2021.03.23.21254185; this version posted March 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

The emergence of multiple new SARS-CoV-2 variants, characterized to varying degrees by
increased infectivity, higher virulence and evasion of vaccine and infection-induced
immunologic memory, has hampered international efforts to contain the virus. While it is
generally believed that these variants first develop in single individuals with poor immunologic
control of the virus, the factors governing variant predominance in the population remain poorly
characterized. Here we present a mathematical framework for variant emergence accounting for
the highly variable number of people secondarily infected by individuals with SARS-CoV-2
infection. Our simulations suggest that threatening new variants probably develop within
infected people fairly commonly, but that most die out and do not achieve permanence in the
population. Variants that predominate are more likely to be associated with higher
infectiousness, but also the occurrence of a super-spreader event soon after introduction into the
population.

medRxiv preprint doi: https://doi.org/10.1101/2021.03.23.21254185; this version posted March 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Introduction

The emergence and subsequent regional predominance of multiple, highly infectious
novel SARS-CoV-2 variants in locations across the globe surprised the scientific and public
health communities. Several variants are characterized by more than a dozen new mutations
often in the genomic region encoding the viral spike protein (1-3). This rate of mutational change
surpassed expectations from previous phylogenetic surveys, which identified population sweeps
with single new point mutations only after multiple generations of infection (4). Immunocompromised hosts are a likely source of these variants. Individuals who have impaired cellmediated or humoral immune function can shed the virus at high viral loads for many weeks,
presumably in the relative absence of immune selection pressure (5-8). Yet, it remains unknown
why certain variants ultimately predominate.
The spread of new variants has had a dramatic impact on global SARS-CoV-2
epidemiology. The B.1.1.7 variant has higher infectivity and virulence than baseline variants (1,
9), while the B.1.3.5.1 and P.1 variants may have the ability to evade vaccine- and infectioninduced immunologic memory (10-12) and may also have higher infectivity and virulence (3, 13,
14). The true abundance of epidemiologically important variants is likely underestimated by
sequencing limitations in many global infection hot spots. The B.1.1.7, B.1.3.5.1 and P.1 variants
may also undergo further important evolutionary changes over time. Here we perform
mathematical modeling to characterize determinants of variant emergence and predominance.

medRxiv preprint doi: https://doi.org/10.1101/2021.03.23.21254185; this version posted March 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Results

Frequent stochastic elimination of new SARS-CoV-2 variants. We previously developed a
mathematical model which captures the highly variable secondary transmission pattern of SARSCoV-2 by fitting to empirically observed distributions of serial intervals within transmission
pairs, as well as distributions of number of secondary transmissions from infected people (1517). The model explains why the majority of infected people do not infect others while a
minority are the index case for large super-spreader events (18-20): the exposure contact network
of infected people is highly over-dispersed meaning that on rare occasions, an infected person
may have dozens of exposure contacts who have the potential to become secondarily infected.
Presumably this phenomenon, which is not observed for influenza (21), is due to aerosolization
of SARS-CoV-2 within crowded indoor environments in which masking is limited (22). For a
super-spreader event to occur, the model projects that the transmitter must also be within the
limited time window when they are shedding at a sufficiently high viral load (15). More model
details are in the Methods.
We adapted this model to assume that new variants emerge from a single infected person.
We then ran individual stochastic simulation to assess whether variants are present after 100 days
or whether they are extinguished. Simulations were governed by an average effective
reproductive number (Re) defined as the mean number of secondary infections created per person
across the entire population, as well as a value for the â€œsuper-spreader parameterâ€ r which
captures the variability of a gamma-distributed exposure contact network: the value is low

medRxiv preprint doi: https://doi.org/10.1101/2021.03.23.21254185; this version posted March 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

(r=0.01) for infections such as influenza in which there is low day-to-day and person-to-person
variance in the number of exposure contacts, and high (r=40) for SARS-CoV-2 (15).
a)

b)

c)

burnout
100%
75%
50%
25%
0%

Figure 1. Percentage of new SARS-CoV-2 variant introductions which burn out after
introduction into the population. Parameter r represents the degree of over-dispersion of
exposure contacts. r=0.1 is a realistic value for influenza infection and r=40 is a realistic
value for SARS-CoV-2 infection. The effective reproductive number (Re) has varied during
the SARS-CoV-2 pandemic depending on the degree of social distancing at a given time.
Scenarios assume a) 1, b) 10 and c) 100 initial cases. New SARS-CoV-2 variants have a high
percentage of burnout when introduced into the population.

For each parameter set, we ran 1000 simulations. We identified that stochastic burnout of
infections is more likely when Re is lower but also when the contact network is highly overdispersed as with SARS-CoV-2 (Figure 1a). This suggests that most highly infectious SARSCoV-2 variants will die out when generated within a single person, even when Re is quite high.
We performed an equivalent analysis with 10 starting infections as might occur if an
outbreak of a new variant first spreads in a small household or work cluster. The rate of burnout
was still relatively high for low Re and high over-dispersion scenarios but decreased substantially
with higher Re values for a given variant (Figure 1b). We next performed an analysis with 100
starting infections as might occur with a larger initial super-spreader event. The rate of burnout
was low for all Re values and assumptions regarding contact network dispersion (Figure 1c).
Therefore, although stochastic extinguishment of novel SARS-CoV-2 variants is likely to be

medRxiv preprint doi: https://doi.org/10.1101/2021.03.23.21254185; this version posted March 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

common, once roughly 100 cases are established, a variant is likely to continue to expand
exponentially in the absence of intensification of non-pharmaceutical interventions (NPIs).

Figure 2. Time to 1000 cumulative infections among SARS-CoV-2 simulations which do not burn out. Scenarios
assume a) 1, b) 10 and c) 100 initial cases. Low Re and low number of initial cases is associated with a higher median
time to reach 1000 cumulative infections as well as larger variance.

Timing of SARS-CoV-2 variant emergence is highly variable at realistic effective reproductive
numbers. We next evaluated time from first case of a new variant to 1000 cumulative infections
in simulations in which stochastic burnout did not occur. We performed 1000 simulations under
each assumed value of Re. When starting with one infection, we observed a wide variance in
time to 1000 infections with an increase in the median time from 23 to 40 days as Re decreased
from 2.2 to 1.2 (Figure 2a). The variance and median time (19 to 38 days) to 1000 infections
were similar when starting from 10 infections (Figure 2b) but the median time (7 to 17 days)
and variance decreased when starting from 100 infections (Figure 2c) again demonstrating that
stochastic forces are less important once 100 cumulative infections are reached.

medRxiv preprint doi: https://doi.org/10.1101/2021.03.23.21254185; this version posted March 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Early super-spreader events as a predictor of rapid progression to high prevalence of
emerging variants. We next examined the timing and number of super-spreader events during
these simulations. Super-spreader events were defined as events in which one person infected a
minimum of 5 (Figure 3a), 10 (Figure 3b) or 20 (Figure 3c) other people in a day. With each
definition and assumed value of Re, the timing of the first super-spreader event correlated with
time to 1000 cumulative infections. The strength of this correlation increased with the least
inclusive definition of a super-spreader event and with higher values for Re (Figure 3c).
c)

b)

a)
Re=1.2

Re=1.2

r=0.21

Re=1.2

r=0.33

Re=1.2

r=0.57

Re=1.4

r=0.38

Re=1.2

r=0.55

Re=1.2

r=-0.17

r=0.32

Re=1.4

Re=1.4

r=0.13

Re=1.4

r=-0.23

Re=1.4

r=0.79

Re=1.4

r=-0.56

Re=1.6

r=0.61

Re=1.6

r=-0.37

r=0.48

Re=1.6

Re=1.8

Re=2.0

Re=2.2

r=0.35

Re=1.6

r=0.44

r=0.34

Re=1.8

r=0.15

r=0.70

Re=2.0

r=0.15

Re=2.2

r=-0.11

r=0.62

Re=1.6

Re=1.8

Re=2.0

Re=2.2

r=0.55

Re=1.6

r=0.55

Re=1.8

r=0.71

Re=2.0

r=0.79

Re=2.2

r=-0.05

r=-0.15

r=0.11

Re=1.8

r=0.76

Re=2.0
r=0.90

r=-0.16

Re=2.2

r=0.94

Re=1.8

r=-0.20

Re=2.0

r=0.0

Re=2.2

r=-0.08

Figure 3. Correlation between timing of super-spreader events and time to 1000 cumulative infections. Scenarios
assume definitions of super-spreader events as a) >=5, b) >=10 and c) >=20 secondary infections per day. Early first superspreader event (left columns) is predictive of more rapid time to 1000 cumulative infections particularly when defined as
>=20 infections per day, whereas number of events (right columns) is less predictive.

medRxiv preprint doi: https://doi.org/10.1101/2021.03.23.21254185; this version posted March 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

The number of super-spreader events prior to 1000 cumulative infections correlated
positively or not at all with time to 1000 cumulative infections for the more inclusive definitions
of super-spreader events (at least 5 or 10 secondary infections, Figure 3a & b) across all Re
values, signifying that multiple small super-spreader events do not accelerate early epidemic
spread. However, the number of super-spreader events correlated negatively with time to 1000
cumulative infections with low to moderate values for Re (1.2-1.8) and less inclusive definitions
of super-spreader events (at least 20 secondary infections, Figure 3c), meaning that early large
super-spreader events are a likely driver of variant predominance under parameter assumptions
which are compatible with known features of variant B.1.1.7 (1).

Increased likelihood of new variant predominance when co-circulating baseline variants have
an effective reproductive number less than or equal to one. We next performed analyses
assuming a baseline variant at different values for Re (0.8, 1.0 or 1.2) with 1000 baseline
infections and assumed that 1% of transmission events result in a new variant. Re for new
variants were drawn from a uniform distribution varying from 1.0-2.2 at intervals of 0.2. For
each scenario, we performed 100 simulations until 100,000 cumulative infections were generated
or until stochastic burnout of all variants occurred. Variants were tracked individually.
Super-spreader events (defined here as >=5 secondarily infected people) were requisite
for new variants to reach 1000 cumulative infections in individual simulations. For example, in
the case of a baseline variant with Re=1.0 and new variant with Re=1.2, 95 variants had a superspreader event, out of which 33 reached 1000 cumulative infections. 905 variants did not have a
super-spreader event, and none reached 1000 cumulative infections (p<2.2x10-16, Fisherâ€™s exact

medRxiv preprint doi: https://doi.org/10.1101/2021.03.23.21254185; this version posted March 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

test). The trend of no variant reaching 1000 cumulative infections in the absence of superspreader events was observed for all assumed values of new variant Re.
a)

b)

c)

d)

Figure 4. New variant predominance depends on timing of variant introduction,
variant effective reproductive number and number of ongoing infections. a) Nine
example simulations starting with 1000 infections of a baseline variant (black line) with
Re=1. New variants are colored lines that are randomly generated in 1% of new infections
and denoted according to Re. The variant which stochastically exceeds 10 cases per day
usually predominates though occasionally an infectious variant will expand more rapidly
(top middle and left). New variants become much more common as incidence increases.
Frequency histograms of Re of new variants with the assumption that b) 1%, c) 0.1% and d)
0.01% of new infections result in new variants with Re of 1.2, 1.4, 1.6, 1.8 or 2.0.

When we assumed a baseline variant (starting with 1000 infected at t=0) with Re=1.0
(Figure 4a), we observed predominance of a new variant in 98 out of 100 simulations (Figure
4b). There was a slightly higher likelihood that more infectious variants with higher Re would
predominate (Figure 4b). The timing of variant predominance was highly variable (Figure 4a).
When we performed the same analysis assuming that 0.1% and 0.01% of transmission events
result in a new variant, then variant takeover only occurred in 44% and 6% of simulations
(Figure 4c, d) with more evenly distributed values of Re. This suggests that the frequency of

medRxiv preprint doi: https://doi.org/10.1101/2021.03.23.21254185; this version posted March 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

variant evolution at the within-host level may determine the characteristics of the predominant
strain at the population level.
When we performed the analysis using a baseline variant with Re=1.2 and 1% of
transmission events resulting in a new variant, then variant takeover only occurred in 42 of 100
of simulations, whereas a baseline variant with Re=0.8 allowed variant takeover in 100 of 100s
simulations with no stochastic burnout of virus. This results explains why new variant
predominance is often observed when incidence of the baseline variant is decreasing (1).

High incidence outbreaks and formation of new variants. In simulations with the baseline
variant Re=1.0, new high incidence waves of infection were predictably associated with
emergence of more new variants some of which ultimately predominated due to higher Re
(Figure 4a, top and middle left panels). This finding highlights that prevention of new variants is
achieved most effectively by avoidance of large waves of infection.

medRxiv preprint doi: https://doi.org/10.1101/2021.03.23.21254185; this version posted March 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Discussion
Our simple mathematical model identifies that while higher infectivity is one important
predictor of a variantâ€™s ultimate predominance in a population, but there is also a substantial
element of bad luck. Stochastic burnout is a common event when a pathogen with a reproductive
number between 1 and 2 is introduced into a population (23). The over-dispersed secondary
infection rate associated with SARS-CoV-2 further increases the likelihood of stochastic burnout
given an equivalent basic reproductive number. This suggests that most new highly infectious
variants which emerge from infected individuals never spread substantially in the population. It
also raises the more provocative hypothesis that human coronaviruses with pandemic potential
such as SARS, MERS and SARS-CoV-2 are introduced into the human population fairly
commonly, but that most local outbreaks are avoided due to good fortune alone.
Among variants which do establish a foothold, our model suggests that early large superspreader events, which are relatively rare at the individual level but become increasingly likely
as incidence increases during a local outbreak, may determine which variant is likely to
predominate. These events provide a head start for a given variant, bypassing the slower
exponential growth phase to a phase of epidemic growth which is more deterministic. Superspreader events later during an epidemic growth curve are relatively less important for a variant
to achieve predominance.
From a public health perspective, our results provide yet another reason to intensely focus
non-pharmaceutical interventions (NPIs) on preventing large super-spreader events. This policy
prescription includes prohibition of large indoor gatherings, a focus on adequate ventilation in
indoor work environments and schools, and enforcement of highest quality masks (K95 or N95)
in circumstances where group exposures cannot be avoided (17). Prevention of super-spreader

medRxiv preprint doi: https://doi.org/10.1101/2021.03.23.21254185; this version posted March 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

events will limit number of infections and lower the introduction of new variants and will also
decrease the probability that a single large super-spreader event will initiate a more rapid local
epidemic as has already occurred in Boston, South Korea and other locations during the
pandemic (24, 25).
Our model has important limitations. While the modelâ€™s qualitative findings are robust,
we cannot estimate the outbreak size necessary to ensure introduction of new variants into a
population as many parameters required to do so are unknown. For instance, it is not yet clear
whether the percentage of immunocompromised hosts varies across populations based on factors
such as HIV prevalence and availability and use of immunosuppression for organ transplantation
and cancer treatment. The number of secondary infections created by a person with new variants
may also differ from that of other members of the population in ways that are difficult to project.
On the one hand, these individuals may shed for longer and at a higher viral load (5, 7). Yet, they
also may be more ill and therefore quarantined at home or in the hospital limiting contact
exposures. Moreover, while all variants will be impacted in the same way by the introduction of
NPIs such as masking and physical distancing, the utilization of these interventions varies
considerably among regions and over time. Our model does not capture these nuances and in this
sense is intended to be phenomenological only.
We demonstrate that new variants are frequently created and introduced into the
population during large waves of SARS-CoV-2 infection. Yet, most variants ultimately burn out
and those that ultimately predominate likely were associated with early super-spreader events.
These variants are most likely to emerge when the previously dominant variant is decreasing.

medRxiv preprint doi: https://doi.org/10.1101/2021.03.23.21254185; this version posted March 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Methods

SARS-CoV-2 within-host model. We used the within-host model describing the SARS-CoV-2
infection from our previous study (16). This model assumes that the contact of SARS-CoV-2 (V)
with susceptible cells (S) produces infected cells at rate Î²VS which then generates new virus at a
per-capita rate Ï€. The model also incorporates the death of infected cells mediated by (1) the
mEr

innate responses (Î´I ! ) and (2) the acquired immune responses (Er+Ï•r ) by SARS-CoV-2-specific
effector cells (E). The magnitude of the innate immunity is dependent on the infected cell density
and the exponent k. The nonlinearity of the acquired responses is captured by the Hill coefficient
r that allows for rapid saturation of the killing. Finally, the parameter Ï• defines level of SARSCoV-2-specific effector cells at which the killing of infected cells becomes half maximal. In the
model, the rise of SARS-CoV-2-specific effector cells rise is described in a two-stage manner.
The first stage defines the proliferation of the first precursor cell compartment (M1 ) at rate Ï‰IM(
and differentiation into a second precursor cell compartment (M2 ) at a per capita rate q. Finally,
second precursor cells differentiate into effector cells at the same per capita rate q and are
cleared at rate Î´E .
The model is expressed as a system of ordinary differential equations:
dS
= âˆ’Î²VS
dt
dI
Er
k
=
Î²VS
âˆ’
Î´I
I
âˆ’
m
r
dt
E +Ï•r
dV
= Ï€I âˆ’ Î³V
dt
dM1
= Ï‰IM1 âˆ’ qM1
dt
dM2
= q(M1 âˆ’ M2 )
dt
dE
dt

= qM2 âˆ’ Î´E E

I
(1)

medRxiv preprint doi: https://doi.org/10.1101/2021.03.23.21254185; this version posted March 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

The initial conditions for the model were assumed as S(0) = 101 cells/mL, I(0) = 1
cells/mL, V(0) =

23(5)
7

copies/mL, M1 (0) = 1, M2 (0) = 0 and E0 = 0. For simulations we

sampled parameter values from a nonlinear mixed-effect model as described in (15), with the
following fixed effects and standard deviation of the random effects (in parenthesis): Log10Î²: 7.23 (0.2) virions-1 day-1; Î´: 3.13 (0.02) day-1 cells-k; k: 0.08 (0.02); Log10(Ï€): 2.59 (0.05) day-1;
m: 3.21 (0.33) days-1cells-1; Log10(Ï‰): -4.55 (0.01) days-1cells-1. We also assumed r = 10; Î´9 =
1 day-1; q = 2.4 Ã— 10:; day-1 and c = 15 day-1.

Dose-response model. We employed our previously developed dose-response model to estimate
the probability of virus entering the airway given a transmitter viral load (i.e., contagiousness)
and the probability of cellular infection given a transmitter viral load, (i.e., infectiousness)
P< [V(t)] (response) based on viral loads V(t) (dose) (15). The relation between the response and
=(<)$

the dose follows, P< [V(t); Î», Î±] = >$ ?=(<)$ , being Î» the viral load that corresponds to 50%
infectiousness and 50% contagiousness and Î± the Hill coefficient that controls the sharpness in
the dose-response curve. We assumed that the viral load-dependent contagiousness (i.e., the
probability that virus is passaged to the exposed personâ€™s airway) is the same as infectiousness.
We estimate the transmission risk as the product of the infectiousness and contagiousness (15).

Transmission model and reproduction number. As in our previous model (26), we determined
the total exposed contacts of a transmitter within a time step (Î”< ) using a gamma distribution, i.e.
A

Î·@% ~Î“ IB , ÏK Î”< , where Î¸ and Ï represent the average daily contact rate and the dispersion
parameter, respectively. The true number of exposure contacts (with viral airway exposure) was

medRxiv preprint doi: https://doi.org/10.1101/2021.03.23.21254185; this version posted March 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

then obtained by multiplying the total exposed contacts and the contagiousness of the transmitter
(i.e., Î¶< = Î·@% P< ). We modelled infectiousness as a Bernoulli event with mean P< , yielding the
number of secondary infections within a time step as T@% = Ber(P< )P< Î·@% . Finally, we summed
up the number of secondary infections over 30 days since the time of exposure to obtain the
individual effective reproduction number, i.e. R C = âˆ‘@% T@% . For each successful transmission,
we further assumed that it takes Ï„ days for the first infected cell to produce virus.
In simple steps, we followed the procedure below to estimate Re,
1. Simulate viral load V(t) of a simulated infected individual using the within-host
model.
2. For a given combination of (Î», Ï„, Î±, Î¸, Ï)
a. For each time step Î”<
i. Compute P< [V(t); Î», Î±]
A

ii. Draw Î·@% ~Î“ IB , ÏK Î”<
iii. Calculate T@% = Ber(P< )P< Î·@%
b. Calculate R C = âˆ‘@% T@%
3. Repeat Steps 1 and 2 to estimate R C for 1,000 infected individuals. The population
level R C can then be calculating by taking the mean of 1,000 individual R C values.

Parameter values for the transmission model. For simulations, we used the parameter set [Î±, Î»,
Ï„, Î¸, Ï] = [0.8, 107, 0.5, 4, 40]) (15) as they most closely reproduces empirically observed
individual R C and serial interval histograms as well as mean R C across individuals ( R 5 âˆˆ
[1.4, 2.5]) and mean serial interval across individuals (SI âˆˆ [4.0, 4.5]) early during the pandemic
(18, 19, 27-29).

medRxiv preprint doi: https://doi.org/10.1101/2021.03.23.21254185; this version posted March 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Simulating temporal dynamics from the transmission model. For a specific scenario with
selected Ï and Î¸, we followed the procedure below to transform the transmission model into
temporal transmission model:
1. Discretize the time-space of 150 days over time steps Î”< of 1 day.
2. With n< representing the number of transmitters at any time t, we start with presumed n5
transmitters at t=0 and zero transmitters at the remaining time points.
3. Starting at t = 0, we first determine the number of transmitters at that time step and then,
a. For each of n< transmitters:
i. Simulate V(T) over [t, t + 30] at daily intervals (i.e., Î”T = 1) using the
within-host model in eq. 1.
ii. Compute PD [V(T); Î», Î±].
A

iii. Draw Î·@D ~Î“ IB , ÏK Î”T.
iv. Calculate T@D = Ber(P< )P< Î·@D .
v. Determine times of successful transmission (t E ) as those times â€˜tâ€™ where
T@D > 0 and the number of secondary transmissions at those time points as
T@D .
vi. Update n<& = n<& + T@D .
4. Repeat Step 3 for t = Î”< , t = 2Î”< and so on over the discretized time-space of 150 days.

Simulating multi-class temporal dynamics from the transmission model. We assumed 7 classes
of mutant strains, each with a different R C of 1.0, 1.2, 1.4, 1.6, 1.8, 2.0 and 2.2. To simulate R C
of 1.0, 1.2, 1.4, 1.6, 1.8, 2.0 and 2.2, we employed Î¸ of 2.3/day, 3.1/day, 3.5/day, 3.75/day,

medRxiv preprint doi: https://doi.org/10.1101/2021.03.23.21254185; this version posted March 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

4.0/day, 5.0/day and 5.5/day, respectively. For a specific scenario with selected Ï, Î¸ and the
probability Âµ of the transmitter transmitting mutant strain, we followed the procedure below to
transform the transmission model into multi-class temporal transmission model:
1. Discretize the time-space of 150 days over time steps Î”< of 1 day.
2. With n<7 representing the number of transmitters at any time t of class â€˜câ€™, we start with
presumed nF7 transmitters at t=0 of class c and zero transmitters at the remaining time points
for all classes.
3. Starting at t = 0, for each of the seven classes,
a. we determine the number of transmitters at that time step of class â€˜câ€™ and then,
b. For each of n<7 transmitters:
i. Simulate V(T) over [t, t + 30] at daily intervals (i.e., Î”T = 1) using the
within-host model in eq. 1.
ii. Compute PD [V(T); Î», Î±].
A

iii. Draw Î·@D ~Î“ IB , ÏK Î”T.
iv. Calculate T@D = Ber(P< )P< Î·@D .
v. Determine times of successful transmission (t E ) as those times â€˜tâ€™ where
T@D > 0 and the number of secondary transmissions at those time points as
T@D .
vi. Determine which strain was transmitted at times of successful transmission
using ÂµD = Ber(Âµ). If ÂµD equals 1, then only a mutant strain is transmitted and
the class of the mutant strain is randomly selected from 7 pre-specified
classes.
vii. Update n<7 = n<7 + T@D .

medRxiv preprint doi: https://doi.org/10.1101/2021.03.23.21254185; this version posted March 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

4. Repeat Step 3 for t = Î”< , t = 2Î”< and so on over the discretized time-space of 150 days.

In the case of ð‘…G = 0.8 (simulated with ðœƒ = 1.1/day), we assume 8 variants instead of 7 and
follow steps 1-4 as mentioned above.

medRxiv preprint doi: https://doi.org/10.1101/2021.03.23.21254185; this version posted March 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

References
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.

18.

N. G. Davies et al., Estimated transmissibility and impact of SARS-CoV-2 lineage
B.1.1.7 in England. Science (2021).
H. Tegally et al., Emergence and rapid spread of a new severe acute respiratory
syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in
South Africa. medRxiv, 2020.2012.2021.20248640 (2020).
N. R. Faria et al., Genomics and epidemiology of a novel SARS-CoV-2 lineage in
Manaus, Brazil. medRxiv, 2021.2002.2026.21252554 (2021).
T. Bedford et al., Cryptic transmission of SARS-CoV-2 in Washington state. Science
370, 571-575 (2020).
B. Choi et al., Persistence and Evolution of SARS-CoV-2 in an Immunocompromised
Host. N Engl J Med 383, 2291-2293 (2020).
A. L. Valesano et al., Temporal dynamics of SARS-CoV-2 mutation accumulation within
and across infected hosts. bioRxiv (2021).
J. H. Baang et al., Prolonged Severe Acute Respiratory Syndrome Coronavirus 2
Replication in an Immunocompromised Patient. J Infect Dis 223, 23-27 (2021).
T. T. Truong et al., Persistent SARS-CoV-2 infection and increasing viral variants in
children and young adults with impaired humoral immunity. medRxiv (2021).
N. G. Davies et al., Increased mortality in community-tested cases of SARS-CoV-2
lineage B.1.1.7. Nature (2021).
W. F. Garcia-Beltran et al., Multiple SARS-CoV-2 variants escape neutralization by
vaccine-induced humoral immunity. Cell (2021).
S. A. Madhi et al., Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the
B.1.351 Variant. N Engl J Med (2021).
S. Cele et al., Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent
plasma. medRxiv, 2021.2001.2026.21250224 (2021).
E. C. Sabino et al., Resurgence of COVID-19 in Manaus, Brazil, despite high
seroprevalence. Lancet (2021).
R. M. Coutinho et al., Model-based estimation of transmissibility and reinfection of
SARS-CoV-2 P.1 variant. medRxiv, 2021.2003.2003.21252706 (2021).
A. Goyal, D. B. Reeves, E. F. Cardozo-Ojeda, J. T. Schiffer, B. T. Mayer, Viral load and
contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events.
Elife 10, e63537 (2021).
A. Goyal, E. F. Cardozo-Ojeda, J. T. Schiffer, Potency and timing of antiviral therapy as
determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory
response. Sci Adv 6, eabc7112 (2020).
A. Goyal, D. B. Reeves, E. F. Cardozo Ojeda, B. T. Mayer, J. T. Schiffer, Slight
reduction in SARS-CoV-2 exposure viral load due to masking results in a significant
reduction in transmission with widespread implementation. medRxiv,
2020.2009.2013.20193508 (2020).
A. Endo, S. Abbott, A. J. Kucharski, S. Funk, C. f. t. M. M. o. I. D. C.-W. Group,
Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside
China. Wellcome Open Res 5, 67 (2020).

medRxiv preprint doi: https://doi.org/10.1101/2021.03.23.21254185; this version posted March 24, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

19.
20.
21.
22.
23.
24.

Q. Bi et al., Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their
close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis 20,
911-919 (2020).
H. L., D. P., C. I., e. al., High SARS-CoV-2 Attack Rate Following Exposure at a Choir
Practice â€” Skagit County, Washington, March 2020. . MMWR Morb Mortal Wkly
Rep 69:606â€“610. (2020).
J. Brugger, C. L. Althaus, Transmission of and susceptibility to seasonal influenza in
Switzerland from 2003 to 2015. Epidemics 30, 100373 (2020).
S. Tang et al., Aerosol transmission of SARS-CoV-2? Evidence, prevention and control.
Environ Int 144, 106039 (2020).
P. Bittihn, R. Golestanian, Stochastic effects on the dynamics of an epidemic due to
population subdivision. Chaos 30, 101102 (2020).
J. E. Lemieux et al., Phylogenetic analysis of SARS-CoV-2 in Boston highlights the
impact of superspreading events. Science 371 (2021).

25.
26.
27.
28.
29.

https://www.cdc.go.kr/board/board.es?mid=a30402000000&bid=0030&act=view
&list_no=366485&tag=&nPage=1 (
A. Goyal, D. B. Reeves, E. F. Cardozo-Ojeda, J. T. Schiffer, B. T. Mayer, Wrong person,
place and time: viral load and contact network structure predict SARS-CoV-2
transmission and super-spreading events. medRxiv, 2020.2008.2007.20169920 (2020).
Y. Zhang, Y. Li, L. Wang, M. Li, X. Zhou, Evaluating Transmission Heterogeneity and
Super-Spreading Event of COVID-19 in a Metropolis of China. Int J Environ Res Public
Health 17 (2020).
Z. Du et al., Serial Interval of COVID-19 among Publicly Reported Confirmed Cases.
Emerg Infect Dis 26 (2020).
D. Adam et al., Clustering and superspreading potential of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infections in Hong Kong. Europe PMC
10.21203/rs.3.rs-29548/v1 (2020).

